C-82 Topical Gel, 1% / PRISM Pharma - LARVOL DELTA

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial (clinicaltrials.gov) - P1/2; N=18; Recruiting; Sponsor: Prism Pharma Co., Ltd.; Trial primary completion date: Jan 2016 ➔ Apr 2016

Trial primary completion date • Biosimilar • Immunology • Systemic Sclerosis